Nebivolol potentiates the efficacy of PDE5 inhibitors to relax corpus cavernosum and penile arteries from diabetic patients by enhancing the NO/cGMP pathway.

Martínez-Salamanca, Juan I

Nebivolol potentiates the efficacy of PDE5 inhibitors to relax corpus cavernosum and penile arteries from diabetic patients by enhancing the NO/cGMP pathway. [electronic resource] - The journal of sexual medicine May 2014 - 1182-92 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1743-6109

10.1111/jsm.12477 doi


Arteries--physiopathology
Benzopyrans--therapeutic use
Carbolines--pharmacology
Cyclic GMP--metabolism
Diabetes Mellitus, Type 2--physiopathology
Drug Synergism
Erectile Dysfunction--drug therapy
Ethanolamines--therapeutic use
Humans
Imidazoles--pharmacology
Male
Middle Aged
Muscle Relaxation--drug effects
Muscle, Smooth, Vascular--drug effects
Nebivolol
Nitric Oxide--metabolism
Penile Erection--drug effects
Penis--blood supply
Phosphodiesterase 5 Inhibitors--pharmacology
Piperazines--pharmacology
Purines--pharmacology
Sildenafil Citrate
Sulfones--pharmacology
Tadalafil
Triazines--pharmacology
Vardenafil Dihydrochloride
Vasodilator Agents--pharmacology